← Open Payments lookup

NPI 1487661930: Open Payments

NPI 1487661930. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$114 in 6 payments from 3 companies in 2025. Trend: 2023 $426 · 2024 $0 · 2025 $114

Food & beverage: $114
CompanyPaymentsAmount
Alkermes, Inc.3$51
Teva Pharmaceuticals USA, Inc.2$47
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$16

Products named: ARISTADA, AUSTEDO XR, CAPLYTA.